AstraZeneca Pharmaceuticals LP

Form 483FOIA Uncovered

Gaithersburg, Maryland, United StatesFEI 1000198729Issued January 30, 2018

View FDA's Record for This Firm

Source: FDA record for this establishment. FDA publishes inspections or enforcement actions for this establishment, listed further down this page, but we have not matched this particular Form 483 to a document or an inspection date FDA has released. It stays out of the default view for that reason. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1000198729.

Observations1

Issue DateJanuary 30, 2018

Status1 Related Warning Letter

Related Inspections10

Establishment Details

Firm: AstraZeneca Pharmaceuticals LP
Location: Gaithersburg, Maryland, United States
FEI Number: 1000198729
Product Type: Drugs
Issue Date: January 30, 2018
Country: United States

Inspection History, 2018 to 2026

NAI9

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

AstraZeneca Pharmaceuticals LP FDA Form 483, Gaithersburg, Maryland, January 30, 2018